Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Tyring

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
The British Journal of Dermatology|September 1, 2018
Comprehensive long-term safety of adalimumab from 18 clinical trials in adult patients with moderate-to-severe plaque psoriasisC Leonardi, K Papp, B Strober, et al.
The Journal of Infectious Diseases|September 5, 1998
Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study. International Valaciclovir HSV Study GroupM Reitano, S Tyring, W Lang, et al.
JAMA|June 28, 2001
Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to womenA Wald, A G Langenberg, K Link, et al.
Annals of Internal Medicine|May 1, 1988
Treatment of condyloma acuminatum with three different interferons administered intralesionally. A double-blind, placebo-controlled trialR C Reichman, D Oakes, W Bonnez, et al.
The British Journal of Dermatology|October 18, 2018
Efficacy and safety of brodalumab in patients with psoriasis who had inadequate responses to ustekinumab: subgroup analysis of two randomized phase III trialsR G Langley, A W Armstrong, M G Lebwohl, et al.
Annals of Internal Medicine|July 15, 1995
Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study GroupS Tyring, R A Barbarash, J E Nahlik, et al.
The Journal of Antimicrobial Chemotherapy|June 18, 1998
A randomized controlled trial of acyclovir versus netivudine for treatment of herpes zoster. International Zoster Study GroupJ Söltz-Szöts, S Tyring, P L Andersen, et al.
The British Journal of Dermatology|February 15, 2017
Open-label study of etanercept treatment in patients with moderate-to-severe plaque psoriasis who lost a satisfactory response to adalimumabJ Bagel, S Tyring, K C Rice, et al.
The British Journal of Ophthalmology|April 24, 2001
Famciclovir for ophthalmic zoster: a randomised aciclovir controlled studyS Tyring, R Engst, C Corriveau, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 12, 2017
Secukinumab demonstrates greater sustained improvements in daily activities and personal relationships than ustekinumab in patients with moderate-to-severe plaque psoriasis: 52-week results from the CLEAR studyA Blauvelt, K Reich, S Mehlis, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
The British Journal of Dermatology|September 1, 2018
Comprehensive long-term safety of adalimumab from 18 clinical trials in adult patients with moderate-to-severe plaque psoriasisC Leonardi, K Papp, B Strober, et al.
The Journal of Infectious Diseases|September 5, 1998
Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study. International Valaciclovir HSV Study GroupM Reitano, S Tyring, W Lang, et al.
JAMA|June 28, 2001
Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to womenA Wald, A G Langenberg, K Link, et al.
Annals of Internal Medicine|May 1, 1988
Treatment of condyloma acuminatum with three different interferons administered intralesionally. A double-blind, placebo-controlled trialR C Reichman, D Oakes, W Bonnez, et al.
The British Journal of Dermatology|October 18, 2018
Efficacy and safety of brodalumab in patients with psoriasis who had inadequate responses to ustekinumab: subgroup analysis of two randomized phase III trialsR G Langley, A W Armstrong, M G Lebwohl, et al.
Annals of Internal Medicine|July 15, 1995
Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study GroupS Tyring, R A Barbarash, J E Nahlik, et al.
The Journal of Antimicrobial Chemotherapy|June 18, 1998
A randomized controlled trial of acyclovir versus netivudine for treatment of herpes zoster. International Zoster Study GroupJ Söltz-Szöts, S Tyring, P L Andersen, et al.
The British Journal of Dermatology|February 15, 2017
Open-label study of etanercept treatment in patients with moderate-to-severe plaque psoriasis who lost a satisfactory response to adalimumabJ Bagel, S Tyring, K C Rice, et al.
The British Journal of Ophthalmology|April 24, 2001
Famciclovir for ophthalmic zoster: a randomised aciclovir controlled studyS Tyring, R Engst, C Corriveau, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 12, 2017
Secukinumab demonstrates greater sustained improvements in daily activities and personal relationships than ustekinumab in patients with moderate-to-severe plaque psoriasis: 52-week results from the CLEAR studyA Blauvelt, K Reich, S Mehlis, et al.
Pageof 4